Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
- PMID: 11593321
- DOI: 10.1038/sj.bmt.1703139
Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Abstract
Community-acquired respiratory virus infections are a cause of mortality after stem cell transplantation (SCT). A prospective study was performed at 37 centers to determine their frequency and importance. Additional cases were also collected to allow the analysis of risk factors for severe infection. Forty episodes were collected in the prospective study and 53 additional episodes through subsequent case collection. The frequency of documented respiratory virus infections was 3.5% among 819 allogeneic and 0.4% among 1154 autologous SCT patients transplanted during the study period. The frequency of lower respiratory tract infections (LRTI) was 2.1% among allogeneic and 0.2% among autologous SCT patients. The mortality within 28 days from diagnosis of a respiratory viral infection was 1.1% among allogeneic SCT while no autologous SCT patient died. The deaths of five patients (0.6%) were directly attributed to a respiratory virus infection (three RSV; two influenza A). On multivariate analysis, lymphocytopenia increased the risk for LRTI (P = 0.008). Lymphocytopenia was also a significant risk factor for LRTI in patients with RSV infections. The overall mortality in RSV infection was 30.4% and the direct RSV-associated mortality was 17.4%. For influenza A virus infection, the corresponding percentages were 23.0% and 15.3%. This prospective study supports the fact that community-acquired respiratory virus infections cause transplant-related mortality after SCT.
Similar articles
-
Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.Transplantation. 2009 Nov 27;88(10):1222-6. doi: 10.1097/TP.0b013e3181bb477e. Transplantation. 2009. PMID: 19935377
-
Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.Bone Marrow Transplant. 2003 Jul;32(1):73-7. doi: 10.1038/sj.bmt.1704048. Bone Marrow Transplant. 2003. PMID: 12815481
-
Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.Bone Marrow Transplant. 2001 Jul;28(1):51-7. doi: 10.1038/sj.bmt.1703083. Bone Marrow Transplant. 2001. PMID: 11498744 Clinical Trial.
-
Influenza and respiratory syncytial virus in the elderly.Expert Rev Vaccines. 2008 Mar;7(2):249-58. doi: 10.1586/14760584.7.2.249. Expert Rev Vaccines. 2008. PMID: 18324893 Review.
-
Immune reconstitution and viral infections after stem cell transplantation.Bone Marrow Transplant. 1998 Apr;21 Suppl 2:S72-4. Bone Marrow Transplant. 1998. PMID: 9630332 Review.
Cited by
-
Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.Biol Blood Marrow Transplant. 2013 Aug;19(8):1220-6. doi: 10.1016/j.bbmt.2013.05.005. Epub 2013 May 13. Biol Blood Marrow Transplant. 2013. PMID: 23680472 Free PMC article.
-
Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant.Front Microbiol. 2018 Dec 12;9:3097. doi: 10.3389/fmicb.2018.03097. eCollection 2018. Front Microbiol. 2018. PMID: 30619176 Free PMC article. Review.
-
Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study.Clin Infect Dis. 2019 May 17;68(11):1894-1903. doi: 10.1093/cid/ciy792. Clin Infect Dis. 2019. PMID: 30239624 Free PMC article.
-
Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.Transpl Infect Dis. 2022 Aug;24(4):e13866. doi: 10.1111/tid.13866. Epub 2022 Jun 1. Transpl Infect Dis. 2022. PMID: 35598293 Free PMC article.
-
Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.Open Forum Infect Dis. 2018 Apr 12;5(5):ofy077. doi: 10.1093/ofid/ofy077. eCollection 2018 May. Open Forum Infect Dis. 2018. PMID: 29780847 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources